76 related articles for article (PubMed ID: 22673577)
1. Novel amphiphilic compounds effectively inactivate the vaccinia virus.
Fedorova AA; Goncharova EP; Ryabchikova EI; Vlasov VV; Zenkova MA
FEBS Lett; 2012 Jun; 586(11):1669-73. PubMed ID: 22673577
[TBL] [Abstract][Full Text] [Related]
2. Artificial ribonucleases inactivate a wide range of viruses using their ribonuclease, membranolytic, and chaotropic-like activities.
Fedorova AA; Goncharova EP; Koroleva LS; Burakova EA; Ryabchikova EI; Bichenkova EV; Silnikov VN; Vlassov VV; Zenkova MA
Antiviral Res; 2016 Sep; 133():73-84. PubMed ID: 27476043
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of a non-enveloped RNA virus by artificial ribonucleases: honey bees and acute bee paralysis virus as a new experimental model for in vivo antiviral activity assessment.
Fedorova AA; Azzami K; Ryabchikova EI; Spitsyna YE; Silnikov VN; Ritter W; Gross HJ; Tautz J; Vlassov VV; Beier H; Zenkova MA
Antiviral Res; 2011 Sep; 91(3):267-77. PubMed ID: 21722669
[TBL] [Abstract][Full Text] [Related]
4. Design, RNA cleavage and antiviral activity of new artificial ribonucleases derived from mono-, di- and tripeptides connected by linkers of different hydrophobicity.
Tamkovich N; Koroleva L; Kovpak M; Goncharova E; Silnikov V; Vlassov V; Zenkova M
Bioorg Med Chem; 2016 Mar; 24(6):1346-55. PubMed ID: 26899594
[TBL] [Abstract][Full Text] [Related]
5. Influenza virus inactivated by artificial ribonucleases as a prospective killed virus vaccine.
Fedorova AA; Goncharova EP; Kovpak MP; Vlassov VV; Zenkova MA
Vaccine; 2012 Apr; 30(19):2973-80. PubMed ID: 22387219
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of West Nile virus, vaccinia virus and viral surrogates for relevant and emergent viral pathogens in plasma-derived products.
Remington KM; Trejo SR; Buczynski G; Li H; Osheroff WP; Brown JP; Renfrow H; Reynolds R; Pifat DY
Vox Sang; 2004 Jul; 87(1):10-8. PubMed ID: 15260817
[TBL] [Abstract][Full Text] [Related]
7. siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects.
Dave RS; McGettigan JP; Qureshi T; Schnell MJ; Nunnari G; Pomerantz RJ
Virology; 2006 May; 348(2):489-97. PubMed ID: 16480752
[TBL] [Abstract][Full Text] [Related]
8. Antiviral evaluation of N-amino-1,2,3-triazoles against Cantagalo virus replication in cell culture.
Jordão AK; Afonso PP; Ferreira VF; de Souza MC; Almeida MC; Beltrame CO; Paiva DP; Wardell SM; Wardell JL; Tiekink ER; Damaso CR; Cunha AC
Eur J Med Chem; 2009 Sep; 44(9):3777-83. PubMed ID: 19481841
[TBL] [Abstract][Full Text] [Related]
9. Artificial ribonucleases: from combinatorial libraries to efficient catalysts of RNA cleavage.
Kovalev N; Burakova E; Silnikov V; Zenkova M; Vlassov V
Bioorg Chem; 2006 Oct; 34(5):274-86. PubMed ID: 16889817
[TBL] [Abstract][Full Text] [Related]
10. Virus inactivation by protein denaturants used in affinity chromatography.
Roberts PL; Lloyd D
Biologicals; 2007 Oct; 35(4):343-7. PubMed ID: 17517521
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence-based antiviral assay for the evaluation of compounds against vaccinia virus, varicella zoster virus and human cytomegalovirus.
Dal Pozzo F; Andrei G; Daelemans D; Winkler M; Piette J; De Clercq E; Snoeck R
J Virol Methods; 2008 Jul; 151(1):66-73. PubMed ID: 18490063
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of substituted 6-methylmercaptopyrazolo(3,4-d)pyrimidines and their ribosides.
Bektemirov TA; Chekunova EV; Korbukh IA; Bulychev YuN ; Yakunina NG; Preobrazhenskaya MN
Acta Virol; 1981 Sep; 25(5):326-9. PubMed ID: 6118054
[TBL] [Abstract][Full Text] [Related]
13. The role of hydrophobic interactions in catalysis of RNA cleavage by 1,4-diazabicyclo[2.2.2]-octane based artificial ribonucleases.
Kuznetsova I; Tuzikov F; Tuzikova N; Tamkovich N; Zenkova M; Vlassov V
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):907-13. PubMed ID: 15560080
[TBL] [Abstract][Full Text] [Related]
14. Lung surfactant DPPG phospholipid inhibits vaccinia virus infection.
Perino J; Crouzier D; Spehner D; Debouzy JC; Garin D; Crance JM; Favier AL
Antiviral Res; 2011 Jan; 89(1):89-97. PubMed ID: 21095206
[TBL] [Abstract][Full Text] [Related]
15. A study of antiviral action of histamine and its complex derivatives; determination of cytotoxicity of those compounds in cell cultures in vitro on the model of vaccinia.
Towiańska A; Potajałło U; Kubica B
Bull Inst Marit Trop Med Gdynia; 1986; 37(1-2):87-101. PubMed ID: 3580633
[No Abstract] [Full Text] [Related]
16. Genetic diversity-independent neutralization of pandemic viruses (e.g. HIV), potentially pandemic (e.g. H5N1 strain of influenza) and carcinogenic (e.g. HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs).
Kotwal GJ
Vaccine; 2008 Jun; 26(24):3055-8. PubMed ID: 18241960
[TBL] [Abstract][Full Text] [Related]
17. On the antiviral activity of diffusomycin (oxazolomycin).
Tonew E; Tonew M; Gräfe U; Zöpel P
Acta Virol; 1992 Mar; 36(2):166-72. PubMed ID: 1359768
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiviral evaluation of analogs of adenosine-N1-oxide and 1-(Benzyloxy)adenosine.
Kwong CD; Krauth CA; Shortnacy-Fowler AT; Arnett G; Hollingshead MG; Shannon WM; Montgomery JA; Secrist JA
Nucleosides Nucleotides; 1998 Aug; 17(8):1409-43. PubMed ID: 9672703
[TBL] [Abstract][Full Text] [Related]
19. [Research on substances with antiviral activity. II. Derivatives of N-substituted 2-chloro-3-formylindoles].
Andreani A; Cavrini V; Giovanninetti G; Mannini Palenzona A; Franchi L
Farmaco Sci; 1975 Jun; 30(6):440-8. PubMed ID: 166871
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of vaccinia virus replication by peptide aptamers.
Saccucci L; Crance JM; Colas P; Bickle M; Garin D; Iseni F
Antiviral Res; 2009 Jun; 82(3):134-40. PubMed ID: 19428604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
